Among over 7000 patients with #cancer, higher baseline fatigue before systemic therapy was linked to an increased risk of severe, life-threatening, and fatal adverse events. ja.ma/4qmZtrt

Great session! Thank you @ryannipp.bsky.social ! Mark your calendars for #ASCOQuality in Boston on 10/16-10/17/2026!

Join us this Thursday to hear the highlights from #ASCOQLTY25 with #ASCOQLTY Chair Elect @ryannipp.bsky.social DM for the link or to be added to our mailing list. @realbowtiedoc.bsky.social @crisbergerot.bsky.social @ericroeland.bsky.social @fionnualacrowley.bsky.social #pallonc

💕 A big “thank you” to our #ASCOQLTY25 Featured Voices! Their expertise and insights are invaluable. We're so lucky to have them! @fumikochino.bsky.social @crisbergerot.bsky.social @ryannipp.bsky.social

Great to hear an expert discussion on #FinancialToxicity from Dr. Jeffrey Peppercorn at #ASCOQLTY25 this afternoon! meetings.asco.org/2025-asco-qu... @ascocancer.bsky.social #PallOnc #SuppOnc #CancerResearch

I am honored to give the #ASCOQLTY25 Simone Award to @drrobinyabroff.bsky.social today. Dr Yabroff has a profound impact as a researcher, policy advocate, & mentor. It's hard to find someone in health services research that hasn't been positively influenced by her intellect, wit, & warmth.🏆

Excellent first session this morning at #ASCO Quality Care Symposium: “Partners in Care: Building Bridges Through Shared Decisions.” meetings.asco.org/meetings/202... #ASCOQLTY25 #CancerCare #CancerResearch @ascocancer.bsky.social

The 2025 @ascocancer.bsky.social Quality Care Symposium #ASCOQLTY25 will feature >600 abstract presentations covering the latest implementation science and the entire spectrum of health services research. 📖 Review abstracts today! ✈️ Join us this weekend in Chicago meetings.asco.org/abstracts-pr...

🚨 #ASCOQLTY25 Registration Alert‼️ (before rates go up this Friday)! 🗣️ Engage in meaningful discussions 🤝 Build lasting relationships 🔋 Leave feeling energized & inspired ➡️ Join us in Chicago Oct 10-11, 2025 @ascocancer.bsky.social www.asco.org/quality/registration-hotels/registration-details

Chair-Elect @ryannipp.bsky.social, MPH, FASCO, attended @ascocancer.bsky.social Quality as a trainee, and the science, education, and community he found there has kept him coming back.   “For many of us, it is our favorite meeting of the year." #ascoQLTY25

Truly honored to be a featured voice at #ASCOQLTY25 alongside such inspiring colleagues who are shaping the future of quality cancer care Join us in Chicago & online, Oct 10–11, for sessions on shared decision-making, advancing quality cancer care and much more @ascocancer.bsky.social

We’re excited to announce the ASCO Quality Care Symposium Featured Voices! Follow them before, during & after the event for expert insights & to be a part of the meeting experience. Join the conversation w/ the official hashtag #ASCOQLTY25. Registration is still open: brnw.ch/21wVoQS

Despite high insurance coverage rates, individuals diagnosed with #cancer in Massachusetts experienced increases in medical debt, with those having bladder and colorectal cancer facing additional increases. ja.ma/4p1IivY

Our study tested GAIN-S in older adults w metastatic cancer 🇧🇷 ➡️ GAIN-S improved emotional + adaptive aspects of prognostic awareness vs usual care Full paper acsjournals.onlinelibrary.wiley.com/doi/10.1002/... Thanks to #WilliamDale #EnriqueSoto @paulobergerot.bsky.social @ryannipp.bsky.social

⏰Discounted access to the 2025 @ascocancer.bsky.social Quality Care Symposium is ending soon! Join us at #ASCOQLTY25 the premier meeting addressing quality, safety, & efficiency of cancer care delivery. 📆 Early Registration by: Wed, September 3 at 11:59 PM (ET)

Clinical trial-related financial considerations from Deep South-patients with breast #cancer who previously declined trial participation. link.springer.com/article/10.1... @cancercaremascc.bsky.social #FinancialToxicity #BreastCancer #CancerResearch @grocquemd.bsky.social @cphilwil.bsky.social

Gather with peers and friends who share your dedication to addressing quality, safety, and efficiency in #CancerCare delivery and join us in Chicago, October 10-11, for #ASCOQLTY25. Early registration closes on Sept. 3. Reserve your space today: brnw.ch/21wUEIk

While phase 3 oncology trials frequently report success based on alternative endpoints, actual enhancements in overall survival and quality of life are uncommon. ja.ma/4f5YdVl

📢 Just published in JNCCN ! Our RCT shows that a telehealth GA & #SuppCare Intervention (GAIN-S) improved physical function, mood & QoL in older Brazilians with metastatic cancer @ryannipp.bsky.social jnccn.org/view/journal...

Malnutrition in Older Adults. www.nejm.org/doi/full/10.... @nejm.org #Geriatrics #GeriOnc #PallOnc

🚨 @oncoalert.bsky.social Deadline Alert TODAY‼️ #ASCOQLTY25 Abstracts are due tonight! Engage in meaningful discussions, build lasting relationships, & leave feeling energized & inspired; join us in Chicago Oct 10-11, 2025. 👉 asco.org/quality @ascocancer.bsky.social

🚨Deadline Alert TOMORROW‼️ 📅 Tuesday, June 10 #ASCOQLTY25 @ascocancer.bsky.social Abstract submissions are due this week! Share your solutions-driven research & help shape the future of quality cancer care. Don’t miss the premier forum for innovation in care delivery! 👉 asco.org/quality

This #ASCOEdBook paper discusses the advances in targeted therapies & immunotherapies to treat #PancreaticCancer & cautions that clinical trials should answer questions that matter to patients. Learn more: brnw.ch/21wTgZn

Connect with us near the Chicago lakefront this autumn to delve into the latest, data-driven, interdisciplinary cancer science aimed at improving the lives of people living with cancer everywhere. Register today for #ASCOQLTY25: brnw.ch/21wTdvO

Always grateful for the #gerionc community that we have and it feels like we have all grown up #fasco #asco25 @mycarg.bsky.social @wilmotcancer.bsky.social @msedrak.bsky.social @ryannipp.bsky.social

Amazing being introduced as #FASCO with my incredible @ascocancer.bsky.social Leadership Development Program friends at #ASCO25. 🙌 Drs Mina Sedrak and @ryannipp.bsky.social

BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. ascopubs.org/doi/full/10.... @ascocancer.bsky.social #ASCO25 #PallOnc #CancerResearch

‼️ #ASCO25 simultaneous publication by Jacobs et al:  BMT-CARE App: A Randomized Controlled Trial of a Psychosocial Digital Application for Caregivers of Patients Undergoing Hematopoietic Stem-Cell Transplantation. Read the full article: ascopubs.org/doi/10.1200/...

Cancer Surveillance in the United States in Jeopardy: Leveraging 21st Century Technology to Enhance Public Health. ascopubs.org/doi/full/10.... @ascocancer.bsky.social @americancancersoc.bsky.social #CancerResearch #CancerCare #Healthcare #MedTech @drrobinyabroff.bsky.social

The most clinically relevant science in oncology will be presented at #ASCO25, and you can now view the full 5,000 abstracts & their presentation date, time & location info: brnw.ch/21wSRrH

Time to Treatment Initiation for the 30 Most Prevalent #Cancer Types: Trends and Predictors of Change. ascopubs.org/doi/10.1200/... @ascocancer.bsky.social #CancerTreatment #CancerResearch #CancerCare

Oncology, Primary Care, and Survivorship: Time for Onco-primary Care? ascopubs.org/doi/10.1200/... @ascocancer.bsky.social #Survivorship #PallOnc #CancerCare @dcrinews.bsky.social @dukemedschool.bsky.social @dukecancer.bsky.social

Last week’s Annual Department of Medicine Research Day at OU Health was a tremendous success. Great event showcasing the outstanding scholarship of our medicine trainees! #MedEd #Research

Early Integration of Outpatient #Palliative Care Among Adults With Advanced #Cancer in a Safety-Net Health System: A Patterns of Care Analysis. ascopubs.org/doi/10.1200/... @ascocancer.bsky.social @pallonccop.bsky.social #PallOnc #hpm #PalliativeCare

Remote Symptom Monitoring With Electronic Patient-Reported Outcomes in Clinical #Cancer Populations. jamanetwork.com/journals/jam... @jama.com @grocquemd.bsky.social @ethanbasch.bsky.social #PallOnc #SuppOnc #CancerResearch

Glory Days: Celebrating Two Decades of Advances in #Cancer Care on the 20th Anniversary of JCO Oncology Practice. ascopubs.org/doi/full/10.... @ascocancer.bsky.social #CancerCare #FinancialToxicity #CancerResearch @ethicsdoctorp.bsky.social @fumikochino.bsky.social @jameabraham.bsky.social

High-Deductible Health Plans and Out-of-Pocket Health Care Costs Among Younger Patients With Multiple Myeloma. ascopubs.org/doi/10.1200/... @ascocancer.bsky.social #FinancialToxicity #CostsOfCare #CancerResearch

An Intervention to Increase Advance Care Planning Among Older Adults With Advanced #Cancer: A Randomized Clinical Trial. jamanetwork.com/journals/jam... @jama.com #GeriOnc #PallOnc #CancerResearch

Improving outcomes of patients with pancreatic #cancer. www.nature.com/articles/s41... @nature.com @natureportfolio.nature.com #PancreaticCancer #CancerResearch #CancerCare @pancan.bsky.social @lustgarten.org

Physician- and Large Language Model–Generated Hospital Discharge Summaries. jamanetwork.com/journals/jam... @jama.com #ArtificialIntelligence #MedTech #DigitalHealth

Adding to growing evidence of #AI -based CT scan muscle analysis in cancer. Pts with mCRC receiving 1L FOLFOX or FOLFIRI with low skeletal muscle index had higher rates of ≥G3 neutropenia. journals.sagepub.com/eprint/RSAKM... #CancerCachexia @ryannipp.bsky.social @pallonccop.bsky.social

Opportunities for Artificial Intelligence in #Oncology: From the Lens of Clinicians and Patients. ascopubs.org/doi/10.1200/... @ascocancer.bsky.social #ArtificialIntelligence #CancerResearch #CancerCare #MedTech #DigitalHealth #AI

The #ASCO25 titles have dropped—all 5,000! Get a sneak peek at the science that will be presented at the ASCO Annual Meeting and start planning out the sessions you’ll attend. Learn more: brnw.ch/21wSaKR

Beyond the Point: Learning From Outcomes After Inpatient Immune Checkpoint Inhibitor Therapy. ascopubs.org/doi/10.1200/... @ascopost.bsky.social @pallonccop.bsky.social #Immunotherapy #CancerResearch @ethicsdoctorp.bsky.social

Many kudos to @ascocancer.bsky.social amazing #SoMe staff for putting together this great highlight of #ASCO25 planning. Getting a moment to hang with the real stars 🤩 inc @ryannipp.bsky.social and my #MedEd colleagues. Looking forward to May in Chicago 🌃

A Digital #Depression Treatment Program for Adults Treated in Primary Care: A Randomized Clinical Trial. jamanetwork.com/journals/jam... @jama.com #DigitalHealth #MedTech #MentalHealth @muschollings.bsky.social

Had a wonderful editorial meeting at @ascocancer.bsky.social headquarters under the leadership of EIC @ethicsdoctorp.bsky.social @acochran12733.bsky.social @fumikochino.bsky.social @ryannipp.bsky.social and others !

Prognostic beliefs in patients with #cancer receiving outpatient #palliative care. link.springer.com/article/10.1... @cancercaremascc.bsky.social #PallOnc #PalliativeCare #CancerResearch

Implementation of Symptom Monitoring With Electronic Patient-Reported Outcomes: Perspectives and Recommendations From Community Oncology Practices (Alliance AFT-39). ascopubs.org/doi/10.1200/... @pallonccop.bsky.social #PallOnc #CancerCare @ethanbasch.bsky.social @biostatgirl.bsky.social

It's been 20 years of JCO OP's publishing impactful info & insights to keep oncology practice current on changes & challenges inherent in delivering equitable, high-quality oncology care with an evolving value-based lens. Editors Meeting today @ascocancer.bsky.social HQ; planning the next 20 years.